Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Schaffert

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2015
mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell FunctionSteven A Schaffert, Christina Loh, Song Wang, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2015
mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell FunctionSteven A Schaffert, Christina Loh, Song Wang, et al.
Pageof 1